Paris — France will stop funding the homeopathic pills and tinctures made by Boiron and rivals at the start of 2021, following the advice of a health panel that spent months reviewing the medicines.

Boiron CEO Valérie Poinsot has said that sales of reimbursed treatments could plummet by 50% in France, where the company brings in almost half its revenue, and at least 1,000 jobs hang in the balance...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.